Related Experiment Video
Updated: Aug 1, 2026

An Intact Pericardium Ischemic Rodent Model
Published on: September 2, 2021
A case report: symptomatic pericarditis post-COVID-19 vaccination
Sarah Ashaari1, Hafiz Ahmed Sohaib1, Kenneth Bolger1
1Department of Medicine, Tipperary University Hospital, Health Service Executive (HSE), Clonmel, Co. Tipperary E91 VY40, Ireland.
Insights
Pericarditis is a rare side effect following the first dose of the Pfizer-BioNTech COVID-19 vaccine. While rare, the benefits of COVID-19 vaccination outweigh potential risks.
Area of Science:
- Cardiology
- Vaccinology
- Infectious Diseases
Background:
- The COVID-19 pandemic spurred rapid vaccine development.
- The CDC noted an increase in myopericarditis post-COVID-19 vaccination.
- Post-vaccination myopericarditis is an infrequent side effect.
Observation:
- A patient developed pericarditis 7 days after their first Pfizer-BioNTech COVID-19 vaccine dose.
- Symptoms included typical pericarditis signs with ECG and echocardiogram changes.
- Investigations ruled out other causes for the patient's condition.
Findings:
- The case presented is pericarditis after the first dose of the Pfizer-BioNTech COVID-19 vaccine.
- The patient experienced symptomatic relief with NSAIDs.
- Literature reports of post-vaccination pericarditis are limited.
Implications:
- While rare, pericarditis is a potential side effect of COVID-19 vaccination.
- The benefits of COVID-19 vaccination continue to outweigh the risks.
- Further research is needed to establish causality due to limited case numbers.
Background:
The Coronavirus disease 2019 (COVID-19) pandemic has led to the rapid development of COVID-19 vaccine. The Centers for Disease Control and Prevention (CDC) has recently reported increase in myopericarditis incidence post-COVID-19 vaccination. Post-vaccination myopericarditis as side effect has been reported, however, is infrequent. We described a case of pericarditis post-first dose of Pfizer-BioNTech vaccine.
Case Summary:
A patient presented with typical symptoms of pericarditis and related electrocardiogram and echocardiogram changes, 7 days post receiving the first dose of COVID-19 vaccine. No other causes were identified from series of investigations. Patient had good symptomatic relief with non-steroidal anti-inflammatory medication.
Discussion:
The incidence of pericarditis post-vaccination is rare, with limited reporting in previous literatures. No causal relationship has yet to be established due to small number of cases. The benefits of COVID-19 vaccination currently outweigh the side effect profile and are recommended as the first-line approach to control the current pandemic.
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis III: Medical Management
Pericarditis I: Introduction
Pericarditis II: Clinical Features and Diagnostic Tests
Pericarditis III: Medical Management
Pericarditis IV: Nursing Management
